The US-India Drug Policy Executive Working Group’s inaugural meeting took place in Washington, emphasizing the joint commitment to combat the global drug challenge. Sara Carter, Director of the US Office of National Drug Control Policy, highlighted the shared dedication of President Trump and Prime Minister Modi to boost security cooperation and combat narco-terrorism.
Ambassador Vinay Kwatra, the Indian Ambassador to the US, stressed India’s top priority in addressing narcotics trafficking threats while balancing enforcement with legitimate trade facilitation. The Executive Working Group, led by officials from both countries, aimed to achieve concrete outcomes in advancing their counter-narcotics partnership.
India and the US are focused on enhancing bilateral cooperation to combat illegal drug production and trafficking, safeguarding communities from the threats posed by illicit drugs and precursor chemicals. Both nations underscored the significance of a comprehensive approach involving various government agencies to secure the pharmaceutical supply chain and disrupt illicit narcotic trafficking networks.
US-India security collaboration has broadened to encompass counterterrorism and law enforcement coordination, with a growing emphasis on counter-narcotics efforts. This partnership is crucial as drug trafficking networks transcend borders and have ties to organized crime and terrorism.
